4//SEC Filing
Velleca Mark A. 4
Accession 0001415889-22-012797
CIK 0001701541other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 9:16 PM ET
Size
5.2 KB
Accession
0001415889-22-012797
Insider Transaction Report
Form 4
Velleca Mark A.
DirectorPRESIDENT & CEO
Transactions
- Award
Common Stock
2022-12-16$1.50/sh+8,424$12,636→ 21,157 total
Footnotes (2)
- [F1]These shares were issued in accordance with the Issuer's Third Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.
- [F2]The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on December 15, 2022.
Documents
Issuer
Black Diamond Therapeutics, Inc.
CIK 0001701541
Entity typeother
Related Parties
1- filerCIK 0001706847
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 9:16 PM ET
- Size
- 5.2 KB